Table 2.
Site of nasal septic focus, microbial organism and antibiotic used
| Pt. | Age/Sex | Septic focus | Duration to onset (days) | Pus (Culture- organism) | Treatment given (I.V.) | Duration of treatment (days) | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | 7/M | Lt nasal vestibule | 05 days | No growth for bacterial culture | Ceftriaxone, metronidazole and amikacin | 16 | Complete recovery |
| 2 | 11/F | Nasal dorsum | 04 days | S. aureus | Ampicillin, metronidazole and vancomycin | 14 | Complete recovery |
| 3 | 16/M | Lt Nasal cavity/Ethmoid sinus | 06 days | S. aureus Streptococcus sp | Piperacillin + tazobactam and vancomycin, + dexamethasone | 18 | Ocular weakness |
| 4 | 15/M | Nasal dorsum | 07 days | S. aureus | Ceftriaxone, metronidazole and amikacin | 14 | Complete recovery |
| 5 | 12/M | Lt nasal cavity/Ethmoid sinus | 10 days | S. aureus | Piperacillin + tazobactam and vancomycin, | 21 | Complete recovery |
| 6 | 11/F | Rt nasal vestibule | 05 days | S. aureus | Ceftriaxone, metronidazole and amikacin | 14 | Complete recovery |
| 7 | 6/M | Bilateral nasal cavity/Ethmoid sinus | 06 days | Streptococcus sp | Amoxycillin + clavulanic acid, metronidazole, amikacin + dexamethasone | 21 | Ocular weakness Vision Loss (Partial) |
| 8 | 12/M | Lt nasal vestibule and columella | 09 days | No growth for bacterial culture | Amoxycillin + clavulanic acid, metronidazole and amikacin | 14 | Complete recovery |
+ Analgesics & Local decongestants given in all